Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/21/23 12:19 | 11/17/23 | HRTX | Health | Drug | Pharmaceutical Preparations | Forbes William P | CA | O | EVP,Chie | P | 27 | 1.09 | 0 | 25 | 46 | 79 | D | ||||||||||||||
11/20/23 10:07 | 11/16/23 | HRTX | Health | Drug | Pharmaceutical Preparations | Forbes William P | CA | O | EVP,Chie | P | 47 | 0.9399 | 0 | 50 | 999% | 54 | D | ||||||||||||||
11/17/23 12:37 | 11/16/23 | HRTX | Health | Drug | Pharmaceutical Preparations | Collard Craig A | CA | DO | CEO | P | 138 | 0.9198 | 0 | 150 | 411 | 186 | D | ||||||||||||||
11/17/23 12:36 | 11/16/23 | HRTX | Health | Drug | Pharmaceutical Preparations | Duarte IRA | CA | O | EVP,CFO | P | 76 | 0.8894 | 0 | 85 | New | 85 | D | ||||||||||||||
7/25/23 16:22 | 7/21/23 | HRTX | Health | Drug | Pharmaceutical Preparations | Morgan Adam | CA | D | P.d | 3,407 | 1.37 | 0 | 2,487 | 55 | 7,025 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |